Medindia

X

Graymark Healthcare Reports Q1 Financial Results - Highlighted by Year-Over-Year Growth

Thursday, May 13, 2010 General News J E 4
Advertisement

(Financial Table Follows)

GRAYMARK HEALTHCARE, INC.

Reconciliation of EBITDA to Net Income

For the Quarters Ended March 31, 2010 and 2009

(unaudited)

2010

2009*

Net Revenues

$27,605,474

$25,471,393

Cost of Sales

(18,477,330)

(17,628,960)

Selling, general and administrative expenses

(9,343,943)

(6,803,354)

Non-controlling Interests

40,799

13,750

EBITDA

($   175,000)

$ 1,052,829

Reconciliation of EBITDA to net income

EBITDA

($   175,000)

$ 1,052,829

Depreciation and amortization

(607,432)

(514,439)

Interest and other expense, net

(594,531)

(520,874)

Provision for income taxes

(47,986)

-

Income from discontinued operations

-

2,197

Net income

($1,424,949)

$     19,713

*Certain 2009 amounts have been reclassified to conform to the current year presentation.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
PAREXEL Strengthens Leading Presence in the Asia/P...
S
Cobalis Corp. Appoints Martin Marion as Chief Exec...